fbpx Skip to main content
  • About Clots
    • Know Your Risk for Blood Clots
      • General Risk Assessment Tool
      • Women’s Risk Assessment Tool
    • Signs and Symptoms of Blood Clots
      • How is DVT diagnosed?
      • How is PE Diagnosed?
    • Prevent Blood Clots
    • Blood Clot Treatment
      • Unfractionated Heparin (UFH)
      • Low Molecular Weight Heparin (LMWH)
      • Warfarin
        • INR Self-Testing
      • Direct Oral Anticoagulants (DOACs)
        • Bleeding Risk Survey
      • Other Treatments
      • Study Results Demonstrate VTE Treatment Satisfaction Among Patients
      • Managing Anticoagulants Before, During, and After Medical Procedures
    • Stop the Clot, Spread the Word®
    • Women & Blood Clots
      • Women’s Risk Assessment Tool
      • Birth Control & Family Planning
      • Pregnancy & Childbirth
      • Treatment of Menopause Symptoms
      • Women’s Health
        • Patient Forum Videos
        • Helping Women Make Choices About Contraception Following DVT Blood Clots
      • Panel Discussion: Blood Clots & Women’s Health
    • COVID-19 and Blood Clotting
      • Frequently Asked Questions: COVID-19 and Blood Clotting
    • Hospitalization and Surgery
      • Stop the Clot, Spread the Word™ Hospitalization
      • Toolkit for Knee and Hip Replacement Patients
    • Cancer and Blood Clots
      • Cancer and Blood Clots – Fast Facts
    • Athletes and Blood Clots
      • Harry Carson, Pro Football Hall of Famer
    • Travel and Blood Clots
    • Thrombophilias
      • Understanding Thrombophilia
      • Genetics of Thrombophilia
    • Health Disparities and the VTE Mississippi Initiative
    • Children, Teenagers & Blood Clots
    • Caregivers
    • Atrial Fibrillation (AFib) and Clot-Provoked Stroke
    • Clinical Trials
    • Additional Resources About Clots
    • Glossary
  • Patient Resources
    • FAQs
    • New Patient Resource Guide
    • Peer Support
    • PEP Talk: Patients Educating Patients
      • PEP Talk Media Library
    • Psychological Impact of Blood Clots
    • Questions to Ask Your Doctor After Having a Blood Clot
    • Your Stories
      • Share Your Story in Writing
      • Share Your Story in Video
  • Health Professionals
    • Healthcare Professional Email Sign Up
    • Online VTE Curriculum – CEs
    • Medical Messages
    • Adherence
    • DVT/PE Awareness Study
      • NBCA Atrial Fibrillation Awareness Survey
  • News
    • 2022 Impact Report
    • Press Room
    • NBCA’s e-Newsletters
      • e-Newsletter Archives
    • NBCA’s e-Magazine
  • Get Involved
    • Email Sign Up
    • How To Help
      • Become a Community Thrombassador
      • NBCA Interest Questionnaire
      • Impact of Blood Clots in the Black Community – Research Opportunities
    • Events
      • 2023 United Airlines NYC Half Marathon
    • NBCA Sports & Wellness Institute: Team Stop the Clot®
      • Team Stop the Clot®
      • Highlights from Team Stop the Clot®
    • Ways to Give
    • DIY Fundraising
    • Volunteer Spotlight
    • NBCA Corporate Roundtable
  • ADVOCACY
    • Advocacy Updates
    • Take Action Now
  • About Us
    • Board of Directors and Officers
    • Council of Emerging Researchers in Thrombosis (CERT)
    • NBCA Team
    • Medical & Scientific Advisory Board (MASAB)
  • Programs & Services
  • Shop
  • Contact Us
MENUMENU
  • About Us
    • Board of Directors and Officers
    • NBCA Team
    • Council of Emerging Researchers in Thrombosis (CERT)
    • Medical & Scientific Advisory Board (MASAB)
      • MASAB Memos
    • NBCA Initiatives
  • Programs & Services
  • Contact Us
  • Shop
Search for:
MENUMENU
  • About Clots
        • Know Your Risk for Blood Clots
          • General Risk Assessment Tool
          • Women's Risk Assessment Tool
        • Signs and Symptoms of Blood Clots
          • How is DVT diagnosed?
          • How is PE Diagnosed?
        • Prevent Blood Clots
        • Blood Clot Treatment
          • Unfractionated Heparin (UFH)
          • Low Molecular Weight Heparin (LMWH)
          • Warfarin
            • INR Self-Testing
          • Direct Oral Anticoagulants (DOACs)
            • Bleeding Risk Survey
          • Other Treatments
          • Study Results Demonstrate VTE Treatment Satisfaction Among Patients
          • Managing Anticoagulants Before, During, and After Medical Procedures
        • Stop the Clot, Spread the Word®
        • COVID-19 and Blood Clotting
          • Frequently Asked Questions: COVID-19 and Blood Clotting
        • Women & Blood Clots
          • Women's Risk Assessment Tool
          • Birth Control & Family Planning
          • Pregnancy & Childbirth
          • Treatment of Menopause Symptoms
          • Women’s Health
            • Patient Forum Videos
            • Helping Women Make Choices About Contraception Following DVT Blood Clots
          • Panel Discussion: Blood Clots & Women’s Health
        • Hospitalization and Surgery
          • Stop the Clot, Spread the Word™ Hospitalization
          • Toolkit for Knee and Hip Replacement Patients
        • Cancer and Blood Clots
          • Cancer and Blood Clots – Fast Facts
        • Athletes and Blood Clots
          • Harry Carson, Pro Football Hall of Famer
        • Travel and Blood Clots
        • Thrombophilias
          • Understanding Thrombophilia
          • Genetics of Thrombophilia
        • Health Disparities and the VTE Mississippi Initiative
        • Children, Teenagers & Blood Clots
        • Caregivers
        • Atrial Fibrillation (AFib) and Clot-Provoked Stroke
        • Clinical Trials
        • Additional Resources About Clots
        • Glossary
  • Patient Resources
    • Your Stories
      • Share Your Story in Writing
      • Share Your Story in Video
    • FAQs
    • New Patient Resource Guide
    • Peer Support
    • PEP Talk: Patients Educating Patients
      • PEP Talk Media Library
    • Psychological Impact of Blood Clots
    • Questions to Ask Your Doctor After Having a Blood Clot
  • Health Professionals
    • Healthcare Professional Email Sign Up
    • Online VTE Curriculum - CEs
    • Medical Messages
    • Adherence
    • DVT/PE Awareness Study
      • NBCA Atrial Fibrillation Awareness Survey
  • News
    • 2022 Impact Report
    • Press Room
    • NBCA’s e-Newsletters
      • e-Newsletter Archives
    • NBCA’s e-Magazine
  • Get Involved
    • Email Sign Up
    • How To Help
      • Become a Community Thrombassador
      • NBCA Interest Questionnaire
      • Impact of Blood Clots in the Black Community – Research Opportunities
    • Events
      • 2023 United Airlines NYC Half Marathon
    • NBCA Sports & Wellness Institute: Team Stop the Clot®
      • Team Stop the Clot®
      • Highlights from Team Stop the Clot®
    • Ways to Give
    • DIY Fundraising
    • Volunteer Spotlight
    • NBCA Corporate Roundtable
  • ADVOCACY
    • Advocacy Updates
    • Take Action Now
  • About Us
    • Board of Directors and Officers
    • Council of Emerging Researchers in Thrombosis (CERT)
    • NBCA Team
    • Medical & Scientific Advisory Board (MASAB)
  • Programs & Services
  • Shop
  • Contact Us
Donate Now
Share
  • About
  • Share
  • Your Stop the Clot® Stories
  • #stoptheclotstory Community

Contact NBCA’s Communications Department with questions or for more information: info@stoptheclot.org

Keep up with the latest news and events

"*" indicates required fields

Email*
This field is for validation purposes and should be left unchanged.
  • About Us
  • Contact Us
  • Privacy Policy
Contact Info

Phone: 703.935.8845
Toll Free: 877.4.NO CLOT

National Blood Clot Alliance
PO Box 825687
Philadelphia, PA 19182-5687

Follow Us
  • Twitter
  • Facebook
  • Email
  • YouTube
  • Pinterest
  • Instagram
Disclaimer

NBCA provides the information and materials on this site for general information purposes only. You should not rely on the information provided as a substitute for actual professional medical advice, care, or treatment. This site is not designed to and does not provide medical advice, professional diagnosis, opinion, treatment, or services to you or any individual. If you believe you have a medical emergency, call 911 immediately.